Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.

"Declarations Ethics approval and consent to participationThe study was performed using a de-identified limited retrospective dataset that was deemed exempt from patient consent by the New England Institutional Review Board/Human Subjects Research Committee (Wellesley, MA, US). The study was conducted in compliance with Health Insurance Portability and Accountability Act requirements. Consent for publicationNot applicable. Competing interestsKSK declares the following: consulting fees from AbbVie, Allecra, Carb-X, Merck, Shionogi, Spero, and Venatorx; and symposia honoraria from GSK. VG was an employee of, and shareholder in, Becton, Dickinson and Company at the time of the analysis, and the company received funding from GSK to conduct this study. AM is an employee of, and shareholder in, GSK. AVJ is an employee of, and shareholder in, GSK. GY was an employee of Becton, Dickinson and Company, and the company received funding from GSK to conduct this study. NESO is an employee of, and shareholder in, GSK. KY is an employee of, and shareholder in, Becton, Dickinson and Company, and the company received funding from GSK to conduct this study. FSMG is an employee of, and shareholder in, GSK. Some of the material discussed in this manuscript was previously presented at Infectious Diseases Week (IDWeek) 2022; Kaye, et al., presentation 2227, “Prevalence, Regional Distribution, and Trends of Antimicrobial Resistance Among Female Outpatients With Urine Klebsiella pneumoniae Isolates: A Multicenter Evaluation”. Competing interests KSK declares the following: consulting fees from AbbVie, Allecra, Carb-X, Merck, Shionogi, Spero, and Venatorx; and symposia honoraria from GSK. VG was an employee of, and shareholder in, Becton, Dickinson and Company at the time of the analysis, and the company received funding from GSK to conduct this study. AM is an employee of, and shareholder in, GSK. AVJ is an employee of, and shareholder in, GSK. GY was an employee of Becton, Dickinson and Company, and the company received funding from GSK to conduct this study. NESO is an employee of, and shareholder in, GSK. KY is an employee of, and shareholder in, Becton, Dickinson and Company, and the company received funding from GSK to conduct this study. FSMG is an employee of, and shareholder in, GSK. Some of the material discussed in this manuscript was previously presented at Infectious Diseases Week (IDWeek) 2022; Kaye, et al., presentation 2227, “Prevalence, Regional Distribution, and Trends of Antimicrobial Resistance Among Female Outpatients With Urine Klebsiella pneumoniae Isolates: A Multicenter Evaluation”."

"Funding This work was supported by GSK (study 212502), including study design, data collection, analysis, interpretation, medical writing, and submission support for the manuscript."